In this study, we demonstrated that lovastatin, a lipophilic statin, activates LKB1‐AMPK‐p38MAPK‐p53‐survivin cascade to cause cell death in MCF‐7 breast cancer cells. The gene discussed is TP53; the disease is breast cancer.